Tracking people at risk for rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 80 years old
- Have certain blood markers that suggest a higher risk of RA, OR be a close relative of someone with RA, OR have a new RA diagnosis
- Not have taken RA medications in the past or currently
- Not have joint swelling that a doctor has noted
- Not be taking high doses of steroids
- Not have certain other autoimmune diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to catch rheumatoid arthritis early using a smartphone tool that records how your hands look and move. If you have early hand pain and a positive ACPA blood test, this study might help detect the disease sooner and guide earlier care.
This study looks at people with very early rheumatoid arthritis to see if a simple blood test and an ultrasound of the neck can show early signs of heart artery damage. The goal is to catch heart disease risk sooner in RA patients.
This study tests an oral drug called AP1189 for people just diagnosed with active rheumatoid arthritis who haven't yet taken standard arthritis medicines. You may be able to take part if your disease is very active and you're ready to try a new treatment option.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study tests a smartphone-based app that tracks hand symptoms to help detect rheumatoid arthritis flares and how well treatment is working. It aims to give patients and doctors an easier way to manage the disease between visits.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.